$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-K Financial Statement

#000114420416125780 Filed on September 28, 2016

Income Statement

Concept	2016 Q3	2015 Q2	2015
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.270M	$1.760M	$6.870M
YoY Change	0.0%	14.29%	53.69%
% of Gross Profit
Research & Development	$2.486M	$1.280M	$4.701M
YoY Change	26.19%	4166.67%	13599.36%
% of Gross Profit
Depreciation & Amortization	$268.4K	$50.00K	$128.9K
YoY Change	281.66%	400.0%	1560.91%
% of Gross Profit
Operating Expenses	$2.486M	$3.090M	$10.70M
YoY Change	-24.66%	38.57%	106.68%
Operating Profit			-$10.70M
YoY Change			106.68%
Interest Expense	$10.00K	$50.00K	$6.729K
YoY Change	519.96%	-77.27%	-99.84%
% of Operating Profit
Other Income/Expense, Net			-$664.5K
YoY Change			-85.41%
Pretax Income	-$3.820M	-$3.040M	-$11.36M
YoY Change	16.11%	51.24%	16.75%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$3.820M	-$3.040M	-$11.36M
YoY Change	16.18%	51.24%	16.77%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$5.380M	-$6.204M	-$27.05M
COMMON SHARES
Basic Shares Outstanding	35.53M shares	24.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q3	2015 Q2	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.370M	$5.280M	$5.280M
YoY Change	43.4%	-10.96%	-10.96%
Cash & Equivalents	$3.370M	$5.280M	$5.280M
Short-Term Investments
Other Short-Term Assets	$360.0K	$320.3K	$770.0K
YoY Change	-29.41%	283.93%	862.5%
Inventory		$67.22K	$70.00K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.730M	$6.116M	$6.120M
YoY Change	22.11%	-3.03%	-3.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.900M	$4.525M	$4.520M
YoY Change	7.35%	1239.0%	1229.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$380.0K	$560.0K	$560.0K
YoY Change	-32.14%	-25.33%	-25.33%
Total Long-Term Assets	$6.330M	$5.147M	$5.140M
YoY Change	3.5%	369.13%	371.56%
TOTAL ASSETS
Total Short-Term Assets	$3.730M	$6.116M	$6.120M
Total Long-Term Assets	$6.330M	$5.147M	$5.140M
Total Assets	$10.06M	$11.26M	$11.26M
YoY Change	9.71%	52.11%	52.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.290M	$1.410M	$1.410M
YoY Change	-22.75%	206.31%	63.95%
Accrued Expenses	$20.00K	$10.00K	$10.00K
YoY Change	100.0%	0.0%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$60.00K	$60.00K	$60.00K
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due	$0.00	$90.00K	$90.00K
YoY Change	-100.0%
Total Short-Term Liabilities	$1.490M	$1.710M	$1.710M
YoY Change	-23.98%	77.38%	78.13%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$20.00K	$20.00K
YoY Change
Other Long-Term Liabilities	$370.0K	$480.0K	$480.0K
YoY Change	-17.78%	1316.72%	1500.0%
Total Long-Term Liabilities	$370.0K	$503.6K	$500.0K
YoY Change	-18.43%	1386.43%	1566.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.490M	$1.710M	$1.710M
Total Long-Term Liabilities	$370.0K	$503.6K	$500.0K
Total Liabilities	$1.850M	$2.209M	$2.210M
YoY Change	-23.24%	121.4%	121.0%
SHAREHOLDERS EQUITY
Retained Earnings		-$29.11M
YoY Change		64.02%
Common Stock		$24.34K
YoY Change		34.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.200M	$9.054M	$9.050M
YoY Change
Total Liabilities & Shareholders Equity	$10.06M	$11.26M	$11.26M
YoY Change	9.71%	52.11%	52.16%

Cashflow Statement

Concept	2016 Q3	2015 Q2	2015
OPERATING ACTIVITIES
Net Income	-$3.820M	-$3.040M	-$11.36M
YoY Change	16.18%	51.24%	16.77%
Depreciation, Depletion And Amortization	$268.4K	$50.00K	$128.9K
YoY Change	281.66%	400.0%	1560.91%
Cash From Operating Activities	-$2.968M	-$1.960M	-$7.080M
YoY Change	18.26%	-6.67%	123.34%
INVESTING ACTIVITIES
Capital Expenditures	-$130.0K	-$2.230M	-$3.160M
YoY Change	-77.59%	3085.71%	4414.29%
Acquisitions
YoY Change
Other Investing Activities	$70.00K	$0.00	-$450.0K
YoY Change	-63.16%	-100.0%	-40.79%
Cash From Investing Activities	-$61.02K	-$2.230M	-$3.610M
YoY Change	-84.35%	171.95%	334.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.333M	1.250M	10.04M
YoY Change	-11765.3%	-61.06%	1.11%
NET CHANGE
Cash From Operating Activities	-$2.968M	-1.960M	-7.080M
Cash From Investing Activities	-$61.02K	-2.230M	-3.610M
Cash From Financing Activities	$2.333M	1.250M	10.04M
Net Change In Cash	-$696.3K	-2.940M	-650.0K
YoY Change	-76.16%	-1113.79%	-110.96%
FREE CASH FLOW
Cash From Operating Activities	-$2.968M	-$1.960M	-$7.080M
Capital Expenditures	-$130.0K	-$2.230M	-$3.160M
Free Cash Flow	-$2.838M	$270.0K	-$3.920M
YoY Change	47.06%	-113.3%	26.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2015Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	23127	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	400038	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	503617	USD
CY2016Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	USD
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1408399	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1500650	USD
CY2015Q2	us-gaap	Assets Assets	11263202	USD
CY2016Q2	us-gaap	Assets Assets	10903391	USD
CY2015Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	563000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	6116384	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	4492107	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	430094	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	119688	USD
CY2015Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	98671	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	381360	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	392855	USD
CY2016Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	23128	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	35114	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	24341	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52782569	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38138754	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44044830	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29109288	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	8772853	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	9053807	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10903391	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11263202	USD
CY2015Q2	us-gaap	Cash Cash	5278706	USD
CY2016Q2	us-gaap	Cash Cash	4062013	USD
CY2016Q2	us-gaap	Liabilities Liabilities	2130538	USD
CY2015Q2	us-gaap	Liabilities Liabilities	2209395	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	450167	USD
CY2016	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	909657	USD
CY2015	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	2068236	USD
CY2016	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	4374763	USD
CY2015	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	742229	USD
CY2016	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	1317465	USD
CY2015	us-gaap	Manufacturing Costs ManufacturingCosts	1355882	USD
CY2016	us-gaap	Manufacturing Costs ManufacturingCosts	2414708	USD
CY2015	antb	Investor Relations InvestorRelations	523345	USD
CY2016	antb	Investor Relations InvestorRelations	259351	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15748	USD
CY2015	antb	Consulting Fees ConsultingFees	349633	USD
CY2016	antb	Consulting Fees ConsultingFees	0	USD
CY2015	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	3778791	USD
CY2016	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	3891916	USD
CY2015	us-gaap	Professional Fees ProfessionalFees	526257	USD
CY2016	us-gaap	Professional Fees ProfessionalFees	441978	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	10697882	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	14951290	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-10697882	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-14951290	USD
CY2015	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	818647	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	4970	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	965	USD
CY2015	us-gaap	Interest Expense InterestExpense	6729	USD
CY2016	us-gaap	Interest Expense InterestExpense	5039	USD
CY2015	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-662723	USD
CY2016	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	19822	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-664482	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-14935542	USD
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.84
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20950191	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24773213	shares
CY2016	antb	Facilities And Other Costs FacilitiesAndOtherCosts	1341452	USD
CY2015	antb	Facilities And Other Costs FacilitiesAndOtherCosts	534862	USD
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5974385	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20909927	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	6026070	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4768123	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10488498	USD
CY2016	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-1216693	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11362364	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2846828	USD
CY2015	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	368419	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3761837	USD
CY2015	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	298419	USD
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2846828	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	3761837	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10725928	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3613124	USD
CY2015	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	67898	USD
CY2016	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	93851	USD
CY2015	antb	Warrant Expense WarrantExpense	93564	USD
CY2016	antb	Warrant Expense WarrantExpense	72972	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-172514	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	6406731	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5523706	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	5974385	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5255	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7292	USD
CY2015	us-gaap	Depreciation Depreciation	128870	USD
CY2016	us-gaap	Depreciation Depreciation	743962	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7078894	USD
CY2015	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-655828	USD
CY2015	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-264716	USD
CY2016	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
CY2015	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2000	USD
CY2016	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2000	USD
CY2015	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	33664	USD
CY2016	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-105484	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10036190	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	42083	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	450167	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-450167	USD
CY2014Q2	us-gaap	Cash Cash	5934534	USD
CY2015	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	3107957	USD
CY2016	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	2091790	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1454123	USD
CY2016	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
CY2015	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	0	USD
CY2015	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	436688	USD
CY2016	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	26370	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	55000	USD
CY2016	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5362521	USD
CY2015	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11175656	USD
CY2016	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	890357	USD
CY2015	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	1071568	USD
CY2016	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	6347615	USD
CY2015	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	USD
CY2016	antb	Forgiveness Of Accounts Payable And Accrued Expenses Related Party ForgivenessOfAccountsPayableAndAccruedExpensesRelatedParty	0	USD
CY2015	antb	Forgiveness Of Accounts Payable And Accrued Expenses Related Party ForgivenessOfAccountsPayableAndAccruedExpensesRelatedParty	-132339	USD
CY2016Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	11955	USD
CY2016	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	19822	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	879250	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	136629	USD
CY2015	antb	Consulting Expenses ConsultingExpenses	99000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7902071	USD
CY2015	antb	Fair Value Of Warrants FairValueOfWarrants	31777	USD
CY2016	antb	Fair Value Of Warrants FairValueOfWarrants	11955	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014Q2	antb	Payments Of Monthly Lease Adjusted Annually Percentage PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage	0.03	pure
CY2014Q2	antb	Adjusted Triple Net Expense Of Lease Payments AdjustedTripleNetExpenseOfLeasePayments	33325	USD
CY2014Q2	us-gaap	Area Of Land AreaOfLand	27000	sqft
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	750000	USD
CY2016	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	187500	USD
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	335747	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	370252	USD
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Entity Registrant Name EntityRegistrantName	AntriaBio, Inc.
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001509261
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015Q4	dei	Entity Public Float EntityPublicFloat	31438587	USD
CY2016	dei	Trading Symbol TradingSymbol	ANTB
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35529097	shares
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35110916	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35110916	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24338219	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24338219	shares
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9448388	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5502902	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5996673	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5307909	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2929084	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3106437	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1480214	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016	us-gaap	Interest Paid InterestPaid	0	USD
CY2015	us-gaap	Interest Paid InterestPaid	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5065733	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3774110	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	339091	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	432092	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5404824	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4206202	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5923200	USD
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2016	antb	Deemed Dividend On Conversion Of Preferred Stock DeemedDividendOnConversionOfPreferredStock	5811708	USD
CY2015	antb	Deemed Dividend On Conversion Of Preferred Stock DeemedDividendOnConversionOfPreferredStock	0	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	162677	USD
CY2015	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10602681	USD
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5170221	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	577110	USD
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	614059	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4395306	USD
CY2015Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3080604	USD
CY2016Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	265809	USD
CY2015Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	412783	USD
CY2016	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	750484	USD
CY2015	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	1745498	USD
CY2016Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15840906	USD
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9277667	USD
CY2016	antb	Warrant Derivative Liability Reclassified As Equity WarrantDerivativeLiabilityReclassifiedAsEquity	0	USD
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14166226	USD
CY2015	antb	Warrant Derivative Liability Reclassified As Equity WarrantDerivativeLiabilityReclassifiedAsEquity	2342039	USD
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8761402	USD
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3863260	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-339091	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-432092	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	12351	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	601808	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	432905	USD
CY2016Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1674680	USD
CY2015Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	516265	USD
CY2016Q2	antb	Deferred Tax Liabilities Non Current Assets DeferredTaxLiabilitiesNonCurrentAssets	1072872	USD
CY2015Q2	antb	Deferred Tax Liabilities Non Current Assets DeferredTaxLiabilitiesNonCurrentAssets	83360	USD
CY2016	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><u>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), formerly known as Fits My Style, Inc., and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio and Antria Delaware are collectively referred to herein as the “Company”.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-5078084	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	229209	USD
CY2016	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2015	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-140059	USD
CY2016Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	27446000	USD
CY2016	antb	Operating Loss Carry Forwards Expiration Year OperatingLossCarryForwardsExpirationYear	2031
CY2016Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6281000	USD
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2016Q2	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1.95
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	512820	shares
CY2016Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000	USD
CY2016	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Reclassifications</i></strong> <i></i> Certain amounts reported in prior years in the Consolidated Financial Statements have been reclassified to conform to the current year’s presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	31777	USD
CY2016	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.
CY2013Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	400000	USD
CY2013Q1	antb	Business Acquisition Purchases Price Allocation Assets Acquired BusinessAcquisitionPurchasesPriceAllocationAssetsAcquired	100000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	55000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4661541	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6863920	USD
CY2015Q4	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series A Stock had a conversion feature at the option of the holder that could be converted at any time at a conversion rate of $1.95, subject to adjustment, into common stock. The shares also had a mandatory conversion feature at the same conversion rate if one of the following events occurs: 1) Upon vote or consent of 2/3 of the then outstanding Series A Stock; 2) Upon the Companys listing to NASDAQ Stockmarket or the NYSE MKT and the Companys common stock trades for 30 days for at least 155% of the Series A Stock conversion price; or 3) the Company closes an underwritten public offering of at least $15 million in gross proceeds with an offering price of at least 155% of the Series A Stock conversion price. The Series A Stocks conversion price was subject to weighted average anti-dilution protection, as defined, and was subject to adjustments for stock splits, dividends, and similar events.
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7292	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7292	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7292	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7292	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7292	USD
CY2016Q2	antb	Minimum Securities Value Purchase Commitments MinimumSecuritiesValuePurchaseCommitments	8000000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Accounting Estimates</i></strong> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: the useful lives of depreciable assets, the fair value of share-based payments and warrants, fair value of derivative instruments, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name	View Source	Status
0001144204-16-125780-index-headers.html	Edgar Link	pending
0001144204-16-125780-index.html	Edgar Link	pending
0001144204-16-125780.txt	Edgar Link	pending
0001144204-16-125780-xbrl.zip	Edgar Link	pending
antb-20160630.xml	Edgar Link	completed
antb-20160630.xsd	Edgar Link	pending
antb-20160630_cal.xml	Edgar Link	unprocessable
antb-20160630_def.xml	Edgar Link	unprocessable
antb-20160630_lab.xml	Edgar Link	unprocessable
antb-20160630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v448917_10k.htm	Edgar Link	pending
v448917_ex10-37.htm	Edgar Link	pending
v448917_ex10-38.htm	Edgar Link	pending
v448917_ex21-1.htm	Edgar Link	pending
v448917_ex31-1.htm	Edgar Link	pending
v448917_ex31-2.htm	Edgar Link	pending
v448917_ex32-1.htm	Edgar Link	pending
v448917_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2016 Q3 Form 10-K Financial Statement

#000114420416125780 Filed on September 28, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2016 Q3 Form 10-K Financial Statement

#000114420416125780 Filed on September 28, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt